Evidence map›Paper›PMID 38322671›Full record

ArticleFrontiers in cellular and infection microbiology2024

Isobavachalcone exhibits antifungal and antibiofilm effects against

Weidong Qian, Jiaxing Lu, Chang Gao, Qiming Liu, Wendi Yao, Ting Wang, Xiaobin Wang, Zhifeng Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Antifungal, anti-biofilm, and anti-hyphal properties ofFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Weidong Qian *School of Biological and Pharmaceutical Engineering, Shaanxi University of Science and Technology, Xi'an, China.
Jiaxing Lu *School of Biological and Pharmaceutical Engineering, Shaanxi University of Science and Technology, Xi'an, China.
Chang GaoSchool of Biological and Pharmaceutical Engineering, Shaanxi University of Science and Technology, Xi'an, China.
Qiming LiuSchool of Biological and Pharmaceutical Engineering, Shaanxi University of Science and Technology, Xi'an, China.
Wendi YaoDepartment of Urology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China.
Ting WangSchool of Biological and Pharmaceutical Engineering, Shaanxi University of Science and Technology, Xi'an, China.
Xiaobin WangDepartment of Urology, Southern University of Science and Technology Hospital, Shenzhen, China.
Zhifeng WangDepartment of Urology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China.
Shaanxi University of Science and Technology · CNZhengzhou University · CNSouthern University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Isobavachalcone (IBC) is a natural flavonoid with multiple pharmacological properties. This study aimed to evaluate the efficacy of IBC against planktonic growth and biofilms of

Indexed as

Antifungal AgentsCandida albicansChalconesApoptosisAutophagyBiofilmsCell MembraneCell WallErgosterolMicrobial Sensitivity TestsAntifungal AgentsChalconesErgosterolisobavachalconeantibiofilmanti-candidaapoptosisautophagyIsobavachalcone

Identifiers

PMID38322671
PMCPMC10845358
OpenAlexW4391108659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.